Yali Friedman, Ph.D. is chief editor of the Journal of Commercial Biotechnology, and publisher of DrugPatentWatch.com. His first book, Building Biotechnology, is used as a course text in dozens of biotechnology programs. His other books include Best Practices in Biotechnology Education and Best Practices in Biotechnology Business Development. He also serves on the science advisory board of Chakra Biotech, and is a judge for the Maryland Incubator Company of the Year Award.
Yali has strong exposure to leading issues in international biotechnology. He is lead editorial consultant for Scientific American's worldVIEW, a global biotechnology perspective profiling biotechnology industries and innovation capacity in dozens of countries since 2009, and has been invited to participate in biotechnology industry development forums for international groups such as APEC and for individual countries such as Japan, Canada, Germany, the Philippines, Turkey, and Taiwan.
Yali taught biotechnology management at the National Institutes of Health for many years and regularly guest-lectures for other biotechnology education programs. He writes and speaks on diverse topics such as biotechnology entrepreneurship, strategies to cope with a lack of management talent and capital when developing companies outside of established hubs, and new paradigms in technology-based economic development.
Yali has a long history in biotechnology media. He created the first blog on the business of biotechnology for a NY Times company, which was named to Forbes "Best of the Web". His other projects include the Student Guide to DNA Based Computers, sponsored by FUJI Television, BiotechBlog.com, and DrugPatentWatch.com, a pharmaceutical industry competitive intelligence service based on a business plan that was awarded second place in the Panasci Entrepreneurial Awards Competition.